Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 13 of 13 entries
View as:

A Study to Evaluate the Safety and Microbiology of C16G2 Varnish Administered in Multiple Doses to Dental Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03004365 Org: User:
Start: 01/27/17 End: 03/29/17 Due: 03/29/18

Individual Patient Expanded Access for AB-SA01, an Investigational Anti-Staphylococcus Aureus Bacteriophage Therapeutic

Phase: N/A Priority: Normal
NCT ID: NCT03395769 Org: User:
Start: - End: - Due: -

Individual Patient Expanded Access for AB-PA01, an Investigational Anti-Pseudomonas Aeruginosa Bacteriophage Therapeutic

Phase: N/A Priority: Normal
NCT ID: NCT03395743 Org: User:
Start: - End: - Due: -

Study to Evaluate the Safety and Microbiology of C16G2 in Adolescent and Adult Dental Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02509845 Org: User:
Start: 07/31/15 End: 03/31/16 Due: 03/31/17

A Study to Evaluate the Microbiology, Safety and Tolerability of C16G2 Dental Strip Application

Phase: N/A Priority: Normal
NCT ID: NCT03052842 Org: User:
Start: 02/09/17 End: 04/05/17 Due: 04/05/18

Phase 2, Open-Label Study for Safety, Microbiology and PK of Single or Multiple Oral C16G2 Gel Doses

Phase: N/A Priority: Normal
NCT ID: NCT02254993 Org: User:
Start: 10/31/14 End: 07/31/15 Due: 07/31/16

Phase 2, Safety & Microbiology Study of C16G2 in Multiple Oral Gel &/or Mouth Rinse Doses to Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT02044081 Org: User:
Start: 02/28/14 End: 08/31/14 Due: 08/31/15

A Phase 2 Study to Evaluate the Microbiology, Safety and Tolerability of C16G2 Varnish and Strip in Adolescent and Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03196219 Org: User:
Start: 07/07/17 End: 01/10/18 Due: 01/10/19

Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02594254 Org: User:
Start: 11/30/15 End: 09/30/16 Due: 09/30/17

Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection

Phase: N/A Priority: Normal
NCT ID: NCT05616221 Org: User:
Start: 01/10/23 End: 08/08/24 Due: 08/08/25

Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia

Phase: N/A Priority: Normal
NCT ID: NCT05184764 Org: User:
Start: 04/26/22 End: 01/14/25 Due: 01/14/26

Ascending Dose Study of the Safety of AB-SA01 When Topically Applied to Intact Skin of Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT02757755 Org: User:
Start: 05/31/16 End: 08/31/16 Due: 08/31/17

Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT04596319 Org: User:
Start: 12/22/20 End: 12/14/22 Due: 12/14/23